Showing results (41-50 of 168) with videos related to
Sort By:
Pageof 17
Gynecologic Oncology|May 9, 2025
Whole-exome sequencing provides assessment of homologous recombination deficiency for identification of PARPi-responsive ovarian tumorsElizabeth Evans, Jhalak Dholakia, Jim Abraham, et al.Neuro-Oncology Advances|November 18, 2024
Biological and prognostic relevance of epigenetic regulatory genes in high-grade gliomasSonikpreet Aulakh, Joanne Xiu, Andrew Hinton, et al.Cancers|December 24, 2021
Genomic and Molecular Profiling of Human Papillomavirus Associated Head and Neck Squamous Cell Carcinoma Treated with Immune Checkpoint Blockade Compared to Survival OutcomesHira Shaikh, Julie E McGrath, Brittany Hughes, et al.The Oncologist|June 6, 2018
Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric AdenocarcinomaMohamed E Salem, Alberto Puccini, Joanne Xiu, et al.Journal of Surgical Oncology|December 15, 2015
Comprehensive multiplatform biomarker analysis of 350 hepatocellular carcinomas identifies potential novel therapeutic optionsCelina Ang, John T Miura, T Clark Gamblin, et al.Neuro-Oncology Advances|July 13, 2022
Molecular alterations associated with improved outcome in patients with glioblastoma treated with Tumor-Treating FieldsManjari Pandey, Joanne Xiu, Sandeep Mittal, et al.Breast Cancer Research and Treatment|August 11, 2020
Actionable co-alterations in breast tumors with pathogenic mutations in the homologous recombination DNA damage repair pathwayArielle L Heeke, Joanne Xiu, Andrew Elliott, et al.NPJ Precision Oncology|July 17, 2025
Multi-omic characterization of early-onset esophagogastric cancerLawrence W Wu, Sachin Kumar Deshmukh, Sharon Wu, et al.Oncotarget|December 2, 2015
Multiplatform molecular profiling identifies potentially targetable biomarkers in malignant phyllodes tumors of the breastZoran Gatalica, Semir Vranic, Anatole Ghazalpour, et al.Neuro-Oncology|April 4, 2017
Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapyTiffany R Hodges, Martina Ott, Joanne Xiu, et al.Pageof 17